Annual EBITDA:
-$68.59M+$8.04M(+10.49%)Summary
- As of today, ABUS annual EBITDA is -$68.59 million, with the most recent change of +$8.04 million (+10.49%) on December 31, 2024.
- During the last 3 years, ABUS annual EBITDA has risen by +$1.30 million (+1.86%).
- ABUS annual EBITDA is now -1384.27% below its all-time high of $5.34 million, reached on December 31, 2006.
Performance
ABUS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$8.28M-$10.21M(-530.46%)Summary
- As of today, ABUS quarterly EBITDA is -$8.28 million, with the most recent change of -$10.21 million (-530.46%) on September 30, 2025.
- Over the past year, ABUS quarterly EBITDA has increased by +$8.85 million (+51.67%).
- ABUS quarterly EBITDA is now -200.64% below its all-time high of $8.23 million, reached on March 1, 2005.
Performance
ABUS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$30.67M+$8.85M(+22.40%)Summary
- As of today, ABUS TTM EBITDA is -$30.67 million, with the most recent change of +$8.85 million (+22.40%) on September 30, 2025.
- Over the past year, ABUS TTM EBITDA has increased by +$46.47 million (+60.24%).
- ABUS TTM EBITDA is now -472.31% below its all-time high of $8.24 million, reached on March 1, 2007.
Performance
ABUS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABUS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.5% | +51.7% | +60.2% |
| 3Y3 Years | +1.9% | +52.0% | +50.0% |
| 5Y5 Years | +1.0% | +43.3% | +41.3% |
ABUS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.0% | +10.5% | -530.5% | +60.6% | at high | +62.1% |
| 5Y | 5-Year | -24.1% | +10.5% | -530.5% | +60.6% | at high | +62.1% |
| All-Time | All-Time | -1384.3% | +10.5% | -200.6% | +63.6% | -472.3% | +62.1% |
ABUS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$8.28M(-530.5%) | -$30.67M(+22.4%) |
| Jun 2025 | - | $1.92M(+115.2%) | -$39.52M(+36.7%) |
| Mar 2025 | - | -$12.70M(-9.3%) | -$62.46M(+8.9%) |
| Dec 2024 | -$68.59M(+10.5%) | -$11.62M(+32.2%) | -$68.59M(+11.1%) |
| Sep 2024 | - | -$17.14M(+18.5%) | -$77.14M(+4.8%) |
| Jun 2024 | - | -$21.02M(-11.6%) | -$80.99M(-3.0%) |
| Mar 2024 | - | -$18.83M(+6.6%) | -$78.65M(-2.6%) |
| Dec 2023 | -$76.63M(-24.0%) | -$20.16M(+3.9%) | -$76.63M(+0.6%) |
| Sep 2023 | - | -$20.98M(-12.3%) | -$77.11M(-5.1%) |
| Jun 2023 | - | -$18.68M(-11.1%) | -$73.38M(-7.6%) |
| Mar 2023 | - | -$16.81M(+18.6%) | -$68.22M(-10.4%) |
| Dec 2022 | -$61.80M(+11.6%) | -$20.65M(-19.7%) | -$61.80M(-0.8%) |
| Sep 2022 | - | -$17.25M(-27.6%) | -$61.33M(-0.2%) |
| Jun 2022 | - | -$13.52M(-30.2%) | -$61.18M(+6.1%) |
| Mar 2022 | - | -$10.38M(+48.6%) | -$65.17M(+6.8%) |
| Dec 2021 | -$69.90M(-26.4%) | -$20.18M(-18.0%) | -$69.90M(-6.9%) |
| Sep 2021 | - | -$17.11M(+2.3%) | -$65.41M(-4.0%) |
| Jun 2021 | - | -$17.51M(-15.9%) | -$62.91M(-8.6%) |
| Mar 2021 | - | -$15.10M(+3.7%) | -$57.92M(-4.7%) |
| Dec 2020 | -$55.29M(+20.2%) | -$15.69M(-7.4%) | -$55.29M(-5.8%) |
| Sep 2020 | - | -$14.61M(-16.7%) | -$52.28M(+6.0%) |
| Jun 2020 | - | -$12.52M(-0.3%) | -$55.59M(+12.2%) |
| Mar 2020 | - | -$12.48M(+1.6%) | -$63.35M(+8.6%) |
| Dec 2019 | -$69.32M(-1.9%) | -$12.68M(+29.3%) | -$69.32M(+3.7%) |
| Sep 2019 | - | -$17.92M(+11.6%) | -$71.95M(-0.4%) |
| Jun 2019 | - | -$20.28M(-9.9%) | -$71.64M(-2.0%) |
| Mar 2019 | - | -$18.45M(-20.5%) | -$70.25M(-3.3%) |
| Dec 2018 | -$68.01M(+0.1%) | -$15.31M(+13.0%) | -$67.99M(+4.9%) |
| Sep 2018 | - | -$17.61M(+6.8%) | -$71.51M(-8.0%) |
| Jun 2018 | - | -$18.89M(-16.7%) | -$66.20M(+0.2%) |
| Mar 2018 | - | -$16.18M(+14.1%) | -$66.32M(+2.6%) |
| Dec 2017 | -$68.11M(-1.3%) | -$18.83M(-53.0%) | -$68.11M(+0.4%) |
| Sep 2017 | - | -$12.30M(+35.3%) | -$68.36M(+4.7%) |
| Jun 2017 | - | -$19.00M(-5.8%) | -$71.74M(+5.0%) |
| Mar 2017 | - | -$17.96M(+5.9%) | -$75.50M(-4.1%) |
| Dec 2016 | -$67.20M(-84.8%) | -$19.08M(-21.7%) | -$72.50M(-24.4%) |
| Sep 2016 | - | -$15.68M(+31.1%) | -$58.29M(-2.4%) |
| Jun 2016 | - | -$22.77M(-52.2%) | -$56.90M(-29.5%) |
| Mar 2016 | - | -$14.96M(-207.1%) | -$43.94M(-20.8%) |
| Dec 2015 | -$36.37M(-12.1%) | -$4.87M(+65.9%) | -$36.37M(+13.7%) |
| Sep 2015 | - | -$14.29M(-45.7%) | -$42.13M(-22.0%) |
| Jun 2015 | - | -$9.81M(-32.8%) | -$34.55M(-1.6%) |
| Mar 2015 | - | -$7.39M(+30.5%) | -$34.01M(-4.8%) |
| Dec 2014 | -$32.44M(-181.1%) | -$10.63M(-58.5%) | -$32.44M(-34.6%) |
| Sep 2014 | - | -$6.71M(+27.6%) | -$24.10M(-15.5%) |
| Jun 2014 | - | -$9.27M(-59.2%) | -$20.86M(-43.6%) |
| Mar 2014 | - | -$5.82M(-154.3%) | -$14.52M(-25.3%) |
| Dec 2013 | -$11.54M(+4.3%) | -$2.29M(+34.0%) | -$11.59M(+22.9%) |
| Sep 2013 | - | -$3.47M(-18.3%) | -$15.04M(-14.5%) |
| Jun 2013 | - | -$2.94M(-1.7%) | -$13.13M(-4.8%) |
| Mar 2013 | - | -$2.89M(+49.7%) | -$12.52M(-4.1%) |
| Dec 2012 | -$12.06M | -$5.74M(-266.7%) | -$12.03M(-48.1%) |
| Sep 2012 | - | -$1.57M(+32.9%) | -$8.12M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$2.33M(+2.5%) | -$8.02M(+12.7%) |
| Mar 2012 | - | -$2.39M(-30.2%) | -$9.18M(+5.0%) |
| Dec 2011 | -$9.63M(-78.4%) | -$1.84M(-26.0%) | -$9.67M(+27.4%) |
| Sep 2011 | - | -$1.46M(+58.3%) | -$13.32M(-60.0%) |
| Jun 2011 | - | -$3.50M(-21.4%) | -$8.33M(-0.0%) |
| Mar 2011 | - | -$2.88M(+47.5%) | -$8.33M(+10.3%) |
| Dec 2010 | -$5.40M(+17.8%) | -$5.49M(-255.2%) | -$9.28M(-64.1%) |
| Sep 2010 | - | $3.54M(+201.2%) | -$5.66M(+49.0%) |
| Jun 2010 | - | -$3.49M(+8.8%) | -$11.09M(-22.2%) |
| Mar 2010 | - | -$3.83M(-105.4%) | -$9.07M(-37.2%) |
| Dec 2009 | -$6.57M(+20.3%) | -$1.87M(+1.9%) | -$6.62M(-20.4%) |
| Sep 2009 | - | -$1.90M(-28.8%) | -$5.49M(+5.8%) |
| Jun 2009 | - | -$1.48M(-7.5%) | -$5.83M(+37.0%) |
| Mar 2009 | - | -$1.37M(-84.6%) | -$9.26M(-7.5%) |
| Dec 2008 | -$8.24M(-392.8%) | -$743.60K(+66.8%) | -$8.61M(-11.9%) |
| Sep 2008 | - | -$2.24M(+54.2%) | -$7.70M(-103.0%) |
| Jun 2008 | - | -$4.90M(-571.9%) | -$3.79M(-374.3%) |
| Mar 2008 | - | -$729.00K(-525.3%) | $1.38M(-50.7%) |
| Dec 2007 | $2.81M(-47.3%) | $171.40K(-89.7%) | $2.80M(+4.4%) |
| Sep 2007 | - | $1.66M(+500.4%) | $2.68M(-47.1%) |
| Jun 2007 | - | $277.00K(-59.9%) | $5.07M(-38.5%) |
| Mar 2007 | - | $691.00K(+1211.2%) | $8.24M(+50.8%) |
| Dec 2006 | $5.34M(+840.5%) | - | - |
| Dec 2006 | - | $52.70K(-98.7%) | $5.46M(+98.8%) |
| Sep 2006 | - | $4.05M(+17.6%) | $2.75M(+181.9%) |
| Jun 2006 | - | $3.44M(+265.4%) | -$3.36M(+66.0%) |
| Mar 2006 | - | -$2.08M(+21.8%) | -$9.86M(-2290.1%) |
| Dec 2005 | $567.90K(+103.4%) | - | - |
| Dec 2005 | - | -$2.66M(-29.4%) | $450.30K(+120.6%) |
| Sep 2005 | - | -$2.06M(+32.8%) | -$2.19M(+48.8%) |
| Jun 2005 | - | -$3.06M(-137.2%) | -$4.27M(+14.9%) |
| Mar 2005 | - | $8.23M(+255.3%) | -$5.02M(+69.8%) |
| Dec 2004 | -$16.82M(+34.6%) | - | - |
| Dec 2004 | - | -$5.30M(-27.9%) | -$16.63M(+13.8%) |
| Sep 2004 | - | -$4.14M(-8.9%) | -$19.30M(+8.2%) |
| Jun 2004 | - | -$3.81M(-12.6%) | -$21.01M(-22.1%) |
| Mar 2004 | - | -$3.38M(+57.6%) | -$17.21M(-24.5%) |
| Dec 2003 | -$25.71M(-16.2%) | - | - |
| Dec 2003 | - | -$7.97M(-36.0%) | -$13.83M(-0.2%) |
| Sep 2003 | - | -$5.86M(+26.3%) | -$13.80M(+37.6%) |
| Dec 2002 | -$22.12M(-72.3%) | - | - |
| Dec 2002 | - | -$7.94M(-25.2%) | -$22.12M(-15.1%) |
| Sep 2002 | - | -$6.35M(-77.5%) | -$19.23M(-24.4%) |
| Jun 2002 | - | -$3.57M(+16.0%) | -$15.45M(-3.2%) |
| Mar 2002 | - | -$4.25M(+15.8%) | -$14.97M(-14.1%) |
| Dec 2001 | -$12.84M(-31.6%) | - | - |
| Dec 2001 | - | -$5.05M(-96.5%) | -$13.12M(-62.6%) |
| Sep 2001 | - | -$2.57M(+17.0%) | -$8.07M(-46.8%) |
| Jun 2001 | - | -$3.10M(-29.0%) | -$5.50M(-129.0%) |
| Mar 2001 | - | -$2.40M | -$2.40M |
| Dec 2000 | -$9.76M(-34.9%) | - | - |
| Dec 1999 | -$7.23M(+17.4%) | - | - |
| Dec 1998 | -$8.75M(-28.1%) | - | - |
| Dec 1997 | -$6.83M | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?
- What is Arbutus Biopharma Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?
- What is Arbutus Biopharma Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?
What is Arbutus Biopharma Corporation annual EBITDA?
The current annual EBITDA of ABUS is -$68.59M
What is the all-time high annual EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual EBITDA is $5.34M
What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?
Over the past year, ABUS annual EBITDA has changed by +$8.04M (+10.49%)
What is Arbutus Biopharma Corporation quarterly EBITDA?
The current quarterly EBITDA of ABUS is -$8.28M
What is the all-time high quarterly EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly EBITDA is $8.23M
What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?
Over the past year, ABUS quarterly EBITDA has changed by +$8.85M (+51.67%)
What is Arbutus Biopharma Corporation TTM EBITDA?
The current TTM EBITDA of ABUS is -$30.67M
What is the all-time high TTM EBITDA for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM EBITDA is $8.24M
What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?
Over the past year, ABUS TTM EBITDA has changed by +$46.47M (+60.24%)